Treatment (μg/mL) | cAMP level (pmol/109 platelets) | TXB2 concentration (pg/mL) | Serotonin concentration (ng/mL) | Intracellular Ca2+ concentration (nM) | |||
---|---|---|---|---|---|---|---|
Collagen | Control | PM21 | IBMX | ||||
 |  |  |  | 0.48 ± 0.12 | 64.63 ± 63.88 | 55.25 ± 31.86 | 139.80 ± 13.70 |
5 | DMSO |  |  | – | 777.76 ± 55.04 | 650.46 ± 38.05 | 2010.70 ± 337.60 |
5 |  | 200 |  | 4.71 ± 0.39*** | 347.50 ± 48.76*** | 369.99 ± 18.64*** | 1288.20 ± 310.20 |
5 |  | 100 |  | 4.35 ± 0.13*** | 468.93 ± 56.76** | 476.14 ± 53.98** | 836.50 ± 88.70** |
5 |  | 50 |  | – | 651.07 ± 84.75 | 358.18 ± 98.73** | 640.70 ± 153.80** |
5 | Aspirin (50 μg/mL) |  |  | 6.81 ± 0.73*** | 389.79 ± 17.00*** | 369.99 ± 20.26*** | 632.30 ± 69.20*** |
5 |  |  | 50 | 2.61 ± 0.16*** |  |  |  |
5 |  | 200 | 50 | 5.59 ± 0.25*** |  |  |  |
5 |  | 100 | 50 | 4.89 ± 0.59** |  |  |  |
5 | Aspirin (50 μg/mL) |  | 50 | 8.11 ± 1.45** |  |  |  |